TriSalus Life Sciences (TLSI) EBITDA

Annual EBITDA

-$58.31 M
-$11.53 M-24.65%

December 31, 2023


Summary


Performance

TLSI EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTLSIprofitabilitymetrics:

Quarterly EBITDA

-$1.09 M
+$2.16 M+66.47%

September 30, 2024


Summary


Performance

TLSI Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTLSIprofitabilitymetrics:

TTM EBITDA

-$52.47 M
+$174.00 K+0.33%

September 30, 2024


Summary


Performance

TLSI TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherTLSIprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

TLSI EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-24.6%+13.8%-14.8%
3 y3 years-119.1%+85.6%-590.5%
5 y5 years-119.1%+85.6%-590.5%

TLSI EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-119.1%at lowat high+96.9%-590.5%+17.0%
5 y5-year-119.1%at lowat high+96.9%-590.5%+17.0%
alltimeall time-119.1%at lowat high+96.9%-590.5%+17.0%

TriSalus Life Sciences EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.09 M(-66.5%)
-$52.47 M(-0.3%)
Jun 2024
-
-$3.25 M(-75.0%)
-$52.64 M(-16.7%)
Mar 2024
-
-$13.03 M(-62.9%)
-$63.20 M(+8.5%)
Dec 2023
-$58.31 M
-$35.10 M(+2674.5%)
-$58.25 M(+27.5%)
Sep 2023
-
-$1.26 M(-90.8%)
-$45.69 M(-13.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$13.81 M(+70.8%)
-$52.52 M(+35.7%)
Mar 2023
-
-$8.08 M(-64.1%)
-$38.71 M(+1.3%)
Dec 2022
-$46.78 M(+75.7%)
-$22.54 M(+178.5%)
-$38.23 M(+143.6%)
Sep 2022
-
-$8.09 M(+6.5%)
-$15.69 M(+106.5%)
Mar 2022
-
-$7.60 M
-$7.60 M
Dec 2021
-$26.62 M
-
-

FAQ

  • What is TriSalus Life Sciences annual EBITDA?
  • What is the all time high annual EBITDA for TriSalus Life Sciences?
  • What is TriSalus Life Sciences annual EBITDA year-on-year change?
  • What is TriSalus Life Sciences quarterly EBITDA?
  • What is the all time high quarterly EBITDA for TriSalus Life Sciences?
  • What is TriSalus Life Sciences quarterly EBITDA year-on-year change?
  • What is TriSalus Life Sciences TTM EBITDA?
  • What is the all time high TTM EBITDA for TriSalus Life Sciences?
  • What is TriSalus Life Sciences TTM EBITDA year-on-year change?

What is TriSalus Life Sciences annual EBITDA?

The current annual EBITDA of TLSI is -$58.31 M

What is the all time high annual EBITDA for TriSalus Life Sciences?

TriSalus Life Sciences all-time high annual EBITDA is -$26.62 M

What is TriSalus Life Sciences annual EBITDA year-on-year change?

Over the past year, TLSI annual EBITDA has changed by -$11.53 M (-24.65%)

What is TriSalus Life Sciences quarterly EBITDA?

The current quarterly EBITDA of TLSI is -$1.09 M

What is the all time high quarterly EBITDA for TriSalus Life Sciences?

TriSalus Life Sciences all-time high quarterly EBITDA is -$1.09 M

What is TriSalus Life Sciences quarterly EBITDA year-on-year change?

Over the past year, TLSI quarterly EBITDA has changed by +$174.00 K (+13.75%)

What is TriSalus Life Sciences TTM EBITDA?

The current TTM EBITDA of TLSI is -$52.47 M

What is the all time high TTM EBITDA for TriSalus Life Sciences?

TriSalus Life Sciences all-time high TTM EBITDA is -$7.60 M

What is TriSalus Life Sciences TTM EBITDA year-on-year change?

Over the past year, TLSI TTM EBITDA has changed by -$6.78 M (-14.83%)